Marine pollution poses significant risks to both marine ecosystems and human health, requiring effective monitoring and control measures. This study presents the Ocean Pollution Monitoring System (OPMS), a web application designed to visualize the seasonal and annual fluctuations of marine pollutants along coastal regions in Canada. The pollutants include fecal coliform and biotoxins such as paralytic shellfish poisoning (PSP), and amnesic shellfish poisoning (ASP).
View Article and Find Full Text PDFBackground And Aims: Glucagon-like peptide 2 (GLP-2) analogues are the first available disease-modifying treatments for patients with intestinal failure (IF) due to short bowel syndrome (SBS). Efficacy in terms of reduction of parenteral support (PS) has been demonstrated in multiple studies and real-world reports. However, it remains unclear how many patients are eligible to receive the treatment, when treatment is started after intestinal resection, how treatment efficacy is assessed outside of clinical trials, and how the treatment is modified in case of non-response or adverse events.
View Article and Find Full Text PDFEsketamine has received approval as a nasal spray (ESK-NS) for treatment-resistant depression (TRD) and evidence from real-world investigations has confirmed the effectiveness of ESK-NS, albeit with interindividual differences in response. Heart rate variability (HRV), defined as the fluctuation in time interval between consecutive heartbeats, can be used to measure autonomic dysfunction in psychiatric disorders and its role has been investigated in diagnosis and prognosis of depression. This preliminary report aims to evaluate HRV parameters and their association with treatment outcome in 18 patients (55.
View Article and Find Full Text PDF